MPs and peers from four parties have written to the Health Secretary and the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) to request the data . They believe potentially critical data have been released to pharmaceutical companies but not put into the public domain . The MPs argue that the data should be released on the same anonymised basis that it was shared with the pharmaceutical groups .